Skip to NavigationSkip to content

Dr Aidan Murphy becomes Ipsen's new Executive VP, Technical Operations

Published on: 10/01/18

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at the end of 2017. In addition to his new position, Dr Murphy will also serve on the French biopharmaceutical company’s executive leadership team.

Dr Murphy has worked in the pharmaceutical and biotechnology industry for more than 25 years, and has served at Ipsen since 2007, boasting a range of manufacturing leadership roles across a number of countries throughout his career. Dr Murphy has held the role of Senior Vice President, Biologics Development and Manufacturing at Ipsen since 2014, and has previously led manufacturing sites in Tianjin in China, Dublin in Ireland, and Wrexham in England during his time with the company.

David Meek, CEO of Ipsen, commented on Dr Murphy’s appointment, remarking: “It is my great pleasure to welcome Aidan to Ipsen’s executive leadership team. He brings outstanding manufacturing leadership experience and an international perspective, having worked across multiple geographies both prior to and during his career with Ipsen. Aidan has played an instrumental role in the transformation of Ipsen Technical Operations in recent years, and the continuity of leadership he brings will be critical as we continue our development as a leading global biopharma company.”

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches